The U.S. Food and Drug Administration has approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In